UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000006900
Receipt No. R000008154
Scientific Title Retinal imaging using optical coherence tomography in various optic neuropathies
Date of disclosure of the study information 2011/12/19
Last modified on 2020/12/23 (Ver. 8)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Retinal imaging using optical coherence tomography in various optic neuropathies
Acronym Retinal imaging using optical coherence tomography in various optic neuropathies
Scientific Title Retinal imaging using optical coherence tomography in various optic neuropathies
Scientific Title:Acronym Retinal imaging using optical coherence tomography in various optic neuropathies
Region
Japan

Condition
Condition Optic neuropathy,Healthy volunteers,
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To take retinal images with optical coherence tomograph and evaluate structural changes in various optic neuropathy.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Retinal layered architecture
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Device,equipment
Interventions/Control_1 To examine eligibility and take OCT images in a day.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria 1.Healthy volunteers, or patients with:
optic neuropathies (e.g. glaucoma, traumatic optic neuropathy)

2. Subjects who sign an informed consent form to participate in the clinical study
Key exclusion criteria Subjects who a doctor in attendance declares ineligible for any reason
Target sample size 300

Research contact person
Name of lead principal investigator
1st name Makoto
Middle name
Last name Nakamura
Organization Kobe University Graduate School of Medicine
Division name Ophthalmology
Zip code 6500017
Address 7-5-1,Kusunoki-cho,Chuo-ku,Kobe
TEL 0783825111
Email ganka@med.kobe-u.ac.jp

Public contact
Name of contact person
1st name Akiyasu
Middle name
Last name Kanamori
Organization Kobe University Graduate School of Medicine
Division name Ophthalmology
Zip code 6500017
Address 7-5-1,Kusunoki-cho,Chuo-ku,Kobe
TEL 0783825111
Homepage URL
Email ganka@med.kobe-u.ac.jp

Sponsor
Institute Department of Ophthalmology, Kobe University Graduate School of Medicine
Institute
Department

Funding Source
Organization Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kobe Univ.I
Address 7-5-1, Kusunokicho, chuoku, Kobe
Tel 078-382-6048
Email kanaaki@med.kobe-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2011 Year 12 Month 19 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2011 Year 12 Month 17 Day
Date of IRB
2012 Year 12 Month 20 Day
Anticipated trial start date
2013 Year 01 Month 01 Day
Last follow-up date
2026 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2011 Year 12 Month 17 Day
Last modified on
2020 Year 12 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000008154